Dr. Nicholas G. Palladino, MD

Dr. Palladino practices at The Shores at Wesley Manor in Ocean City, New Jersey.

Dr. Palladino's NPI, 1639116569, was assigned on May 31, 2006. Dr. Palladino holds New Jersey license 25MA06548800.

Dr. Palladino's primary practice is The Shores at Wesley Manor, at 2201 Bay Ave, Ocean City, NJ 08226 in Cape May County. The practice phone is (609) 399-8505.

Dr. Palladino's primary practice is The Shores at Wesley Manor in Ocean City, New Jersey. Dr. Palladino is also affiliated with Cooper University Hospital. The medical group on file is Advocare. Dmand AI also links Dr. Palladino to 1 more hospital, 5 hospices, 5 skilled nursing facilities, 3 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Palladino practices, 16 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Palladino's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Palladino is licensed in New Jersey.

CMS data shows 9,742 Medicare services from Dr. Palladino across 11 procedure codes in 2024, for 931 Medicare patients. Medicare paid $622,687 for them.

CMS counts 931 Medicare patients who saw Dr. Palladino in 2024. The largest group is 85 and over, with 433 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Palladino's median patient age at 79, with 57% women.

In 2024, Dr. Palladino wrote 42,466 Medicare Part D claims for 1,055 patients. 88% of them were for generic drugs. CMS names the drug for 41,556 of them, across 319 drugs with 11 or more claims each, at $2,217,240 in total drug cost. In 2023, CMS named 42,935 claims across 318 drugs.

Dr. Palladino accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 563 general payments to Dr. Palladino from 50 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Avanir Pharmaceuticals, Inc. paid the most, $88,815.